CA Mullen

646 total citations
13 papers, 489 citations indexed

About

CA Mullen is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, CA Mullen has authored 13 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in CA Mullen's work include Hematopoietic Stem Cell Transplantation (5 papers), Virus-based gene therapy research (4 papers) and Herpesvirus Infections and Treatments (2 papers). CA Mullen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Virus-based gene therapy research (4 papers) and Herpesvirus Infections and Treatments (2 papers). CA Mullen collaborates with scholars based in United States and Japan. CA Mullen's co-authors include R. Michael Blaese, K. Arnold Chan, Zvi Ram, Riad Agbaria, E H Oldfield, Hiroyuki Hirano, Sandesh Subramanya, Mary Choroszy, W. Jay Ramsey and Hai T. Tran and has published in prestigious journals such as Blood, Molecular Pharmacology and European Journal of Cancer.

In The Last Decade

CA Mullen

13 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CA Mullen United States 11 201 144 129 111 109 13 489
Thomas B. Okarma United States 12 187 0.9× 101 0.7× 234 1.8× 91 0.8× 55 0.5× 21 527
Karen Crain United States 10 73 0.4× 236 1.6× 210 1.6× 35 0.3× 46 0.4× 11 548
Ursula Holzer Germany 17 69 0.3× 208 1.4× 183 1.4× 125 1.1× 86 0.8× 45 729
T Shikano Japan 16 255 1.3× 177 1.2× 216 1.7× 227 2.0× 65 0.6× 28 648
F Le Deist France 16 105 0.5× 95 0.7× 123 1.0× 96 0.9× 73 0.7× 28 607
LS Park Australia 9 55 0.3× 137 1.0× 97 0.8× 110 1.0× 29 0.3× 18 500
N Duinkerken Netherlands 10 55 0.3× 156 1.1× 113 0.9× 119 1.1× 35 0.3× 15 539
CN Abboud United States 15 48 0.2× 211 1.5× 113 0.9× 130 1.2× 34 0.3× 26 593
Andrew G. Hadley United Kingdom 20 215 1.1× 573 4.0× 270 2.1× 40 0.4× 31 0.3× 42 962
Harold H. Handley United States 14 61 0.3× 53 0.4× 221 1.7× 73 0.7× 30 0.3× 22 560

Countries citing papers authored by CA Mullen

Since Specialization
Citations

This map shows the geographic impact of CA Mullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CA Mullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CA Mullen more than expected).

Fields of papers citing papers by CA Mullen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CA Mullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CA Mullen. The network helps show where CA Mullen may publish in the future.

Co-authorship network of co-authors of CA Mullen

This figure shows the co-authorship network connecting the top 25 collaborators of CA Mullen. A scholar is included among the top collaborators of CA Mullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CA Mullen. CA Mullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Petropoulos, Demetrios, Laura L. Worth, CA Mullen, et al.. (2006). Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies. Bone Marrow Transplantation. 37(5). 463–467. 20 indexed citations
2.
Chan, KW, et al.. (2002). Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplantation. 29(12). 963–965. 31 indexed citations
3.
Mullen, CA, et al.. (2000). Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Transplantation. 25(1). 59–65. 34 indexed citations
4.
5.
Przepiorka, Donna, et al.. (1999). Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation. Bone Marrow Transplantation. 23(12). 1291–1295. 24 indexed citations
6.
Kuriyama, Shigeki, Kazuhiro Masui, Takemi Sakamoto, et al.. (1998). Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.. PubMed. 18(5A). 3399–406. 43 indexed citations
7.
Agbaria, Riad, CA Mullen, Hiroyuki Hirano, et al.. (1997). Mechanism of ‘bystander effect’ killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Therapy. 4(3). 244–251. 104 indexed citations
8.
Ramsey, W. Jay, CA Mullen, & R. Michael Blaese. (1995). Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.. PubMed. 9 Suppl 1. S70–S70. 2 indexed citations
9.
Blaese, R. Michael, et al.. (1994). In situ delivery of suicide genes for cancer treatment. European Journal of Cancer. 30(8). 1190–1193. 31 indexed citations
10.
Agbaria, Riad, CA Mullen, Neil R. Hartman, et al.. (1994). Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.. Molecular Pharmacology. 45(4). 777–782. 11 indexed citations
11.
Blaese, R. Michael, CA Mullen, & W. Jay Ramsey. (1993). Strategies for gene therapy.. PubMed. 41(8). 672–6. 13 indexed citations
12.
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas B. Okarma Breakdown of academic impact, for papers by Karen Crain Breakdown of academic impact, for papers by Ursula Holzer Breakdown of academic impact, for papers by T Shikano Breakdown of academic impact, for papers by F Le Deist Breakdown of academic impact, for papers by LS Park Breakdown of academic impact, for papers by N Duinkerken Breakdown of academic impact, for papers by CN Abboud Breakdown of academic impact, for papers by Andrew G. Hadley Breakdown of academic impact, for papers by Harold H. Handley
Rankless by CCL
2026